SXTC — China SXT Pharmaceuticals, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723980 ·
China
Last close
$2.55
Market Cap
$97.46M
52W High
$2.93
52W Low
$1.41
ADV30
113,184
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 34,754,574 | 28,175,865 | 5,047,152 |
| Sep 2025 | — | — | — | — | 26,353,283 | 21,166,494 | 6,119,748 |
| Mar 2025 | — | — | — | — | 21,663,508 | 18,099,019 | 6,223,746 |
| Sep 2024 | — | — | — | — | 29,990,005 | — | 19,808,210 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-34,384,120
Inventory
$751,346
Receivables
$2,865,377
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,138,052
EBITDA
$-7,049,265
Free Cash Flow
$-4,736,071
Enterprise Value
$54,311,896
Total Cash
$28,320,836
Total Debt
$1,120,986
Shares Out
38,218,077
Trailing EPS
$-9.13
Book Value
$26.16
ROE
-27.5%
ROA
-15.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,138,052 | -7,122,933 | -6,205,085 | 34,754,574 | 5,047,152 | — | -4,017,456 |
| Mar 2025 | 1,740,907 | -2,680,479 | -3,303,652 | 21,663,508 | 6,223,746 | — | -2,345,333 |
| Mar 2024 | 1,928,497 | -2,515,217 | -3,098,532 | 23,127,057 | 9,196,611 | — | -1,928,053 |
| Mar 2023 | 1,971,679 | -5,607,509 | -5,934,772 | 29,554,056 | 14,862,761 | — | -80,757 |
| Mar 2022 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INO | INOVIO PHARMACEUTICALS, INC. | $97.08M | $1.18 | — |
| ATHE | ALTERITY THERAPEUTICS LTD | $98.42M | $5.43 | — |
| HSTC | HST Global, Inc. | $99.00M | $0.70 | — |
| BMEA | Biomea Fusion, Inc. | $95.44M | $1.32 | — |
| RVRC | Revium Rx. | $101.42M | $1.67 | — |
News headlines (Yahoo Finance, 1h cache)
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
2026-03-23 13:00 · Yahoo
BC-Most Active Stocks
2026-02-02 15:30 · Yahoo
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
2026-01-30 14:00 · Yahoo
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
2026-01-15 14:00 · Yahoo
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
2026-01-13 22:00 · Yahoo
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
2026-01-09 19:50 · Yahoo
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT
2026-01-08 14:20 · Yahoo
China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024)
2025-08-02 13:55 · Yahoo
US Market's Undiscovered Gems Featuring 3 Promising Stocks
2025-07-31 17:33 · Yahoo
Undiscovered Gems in the US Market for July 2025
2025-07-31 11:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.